Suggestions

Du même auteur

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component

Archive ouverte | Guglielmetti, Lorenzo | CCSD

International audience. Rifapentine, a synthetic derivate of rifampicin which was developed in 1965, has interesting pharmacological properties, including a long terminal half-life (13 h, compared to 2-3 h for rifam...

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria

Archive ouverte | van Leth, Frank | CCSD

International audience

Availability and costs of medicines for the treatment of tuberculosis in Europe

Archive ouverte | Günther, Gunar | CCSD

International audience

Chargement des enrichissements...